Citadel Advisors’s VanEck Vectors Generic Drugs ETF GNRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,661	Closed	-$259K	–	4746
2017 Q4	$259K	Buy	+10,661	New	+$259K	﹤0.01%	3224
2017 Q3	–	Sell	-15,717	Closed	-$354K	–	4466
2017 Q2	$354K	Sell	15,717 -8,970	-36%	-$202K	﹤0.01%	2800
2017 Q1	$558K	Buy	+24,687	New	+$558K	﹤0.01%	2503